Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer H Martin

Showing results (1-10 of 184) with videos related to

Pageof 19
Sort By:
Internal Medicine Journal|December 5, 2023
The valley of death: why Australia failed to develop clinically effective drugs in COVID-19Jennifer H Martin
British Journal of Clinical Pharmacology|June 15, 2020
Effect of pharmaceutical regulatory policy on health impactJennifer H Martin
Internal Medicine Journal|February 16, 2017
IntroductionJennifer H Martin
British Journal of Clinical Pharmacology|May 17, 2018
Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modellingZheng Liu, Jennifer H Martin
Internal Medicine Journal|October 20, 2022
Complementary and alternative therapies in the palliative settingJennifer H Martin, Joanne Patel
British Journal of Clinical Pharmacology|May 12, 2019
The rationale of dose-response curves in selecting cancer drug dosingJennifer H Martin, Simon Dimmitt
British Journal of Clinical Pharmacology|September 22, 2020
A pharmacological framework for integrating treating the host, drug repurposing and the damage response framework in COVID-19Jennifer H Martin, Richard Head
British Journal of Clinical Pharmacology|December 14, 2020
Precision medicine-based drug treatment individualization in oncologyJennifer H Martin, Ian Olver
Australian Prescriber|March 5, 2021
Reporting adverse drug events to the Therapeutic Goods AdministrationJennifer H Martin, Catherine Lucas
Journal of Psychopharmacology (Oxford, England)|April 28, 2021
Easier patient access to medical cannabis carries risks as well as benefitsWayne Hall, Jennifer H Martin
Pageof 19

Showing results (1-10 of 184) with videos related to

Sort By:
Pageof 19
Internal Medicine Journal|December 5, 2023
The valley of death: why Australia failed to develop clinically effective drugs in COVID-19Jennifer H Martin
British Journal of Clinical Pharmacology|June 15, 2020
Effect of pharmaceutical regulatory policy on health impactJennifer H Martin
Internal Medicine Journal|February 16, 2017
IntroductionJennifer H Martin
British Journal of Clinical Pharmacology|May 17, 2018
Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modellingZheng Liu, Jennifer H Martin
Internal Medicine Journal|October 20, 2022
Complementary and alternative therapies in the palliative settingJennifer H Martin, Joanne Patel
British Journal of Clinical Pharmacology|May 12, 2019
The rationale of dose-response curves in selecting cancer drug dosingJennifer H Martin, Simon Dimmitt
British Journal of Clinical Pharmacology|September 22, 2020
A pharmacological framework for integrating treating the host, drug repurposing and the damage response framework in COVID-19Jennifer H Martin, Richard Head
British Journal of Clinical Pharmacology|December 14, 2020
Precision medicine-based drug treatment individualization in oncologyJennifer H Martin, Ian Olver
Australian Prescriber|March 5, 2021
Reporting adverse drug events to the Therapeutic Goods AdministrationJennifer H Martin, Catherine Lucas
Journal of Psychopharmacology (Oxford, England)|April 28, 2021
Easier patient access to medical cannabis carries risks as well as benefitsWayne Hall, Jennifer H Martin
Pageof 19